Regions

Foley & Lardner's Nathaniel Lacktman and Louis Lehot discuss which categories of digital health hold the most potential for M&As and why in this contributed piece.

Dr. Michael Howell, Google's chief clinical officer, discusses what federal regulators should consider while configuring rules around AI use in healthcare and how the company ensures health equity within its medically tuned LLM, Med-PaLM.  

The tech giant revealed it created an LLM optimized for diagnostic reasoning with the ability to generate a differential diagnosis or assist clinicians in coming to a diagnosis.

Embark on the AI journey with a bold mindset, says Sunil Dadlani, Atlantic Health System's chief information and digital officer (and CISO). Still, review the technology and address the risks upfront to ensure proper guardrails for safety.  

Execs overwhelmingly cite genAI as having the most significant impact in healthcare this year, though others provide alternative takes on the years' events.

Dr Mohammad Adib Khumaidi, president of the Indonesian Medical Association, says industry collaboration is necessary during this "new technologic era" to further digital adoption and improve the medical provider and patient experience.  

The telehealth company is also betting on secondary care.

The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.

The partners will initially launch in two clinics in Texas to provide patients with ALS access to virtual-first specialty care providers, including respiratory therapists.